CYCN
Cyclerion Therapeutics, Inc. · Healthcare
President and CSO Mark G Currie sold $61K of Cyclerion Therapeutics, Inc.
Sold$60,522
$3.01Price
20,107Shares
−7%Stake
What CYCN did after the filing
- The stock from Wed, Dec 30 open, $60.00
- +43.3%
- S&P 500, same days
- +5.5%
Measured over 30 trading days, to the Feb 12 close.
Traded Mon, Dec 28. Filed Wed, Dec 30, 8:14 AM ET, before the open. Returns use the Dec 30 open and the Feb 12 close. Not investment advice.